Published in Clin Infect Dis on July 01, 1996
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Developments in fungal taxonomy. Clin Microbiol Rev (1999) 2.39
In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother (2002) 2.36
Molecular variability of Pseudallescheria boydii, a neurotropic opportunist. J Clin Microbiol (2000) 1.41
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother (2002) 1.01
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1997) 0.98
Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation. Eur Radiol (2005) 0.86
Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol (2000) 0.84
Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother (2004) 0.83
Fatal Scedosporium prolificans infection in a leukemic patient. Eur J Clin Microbiol Infect Dis (1997) 0.76
Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol (2000) 3.46
Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache (1999) 2.61
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology (2004) 2.41
Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine (2000) 2.38
Accuracy of genomic selection methods in a standard data set of loblolly pine (Pinus taeda L.). Genetics (2012) 2.33
Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology (2002) 2.16
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol (2000) 2.08
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00
Evaluation of an immunological score to assess the risk of severe infection in heart recipients. Transpl Infect Dis (2014) 1.98
[A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome]. Rev Esp Enferm Dig (1991) 1.94
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.83
Insertional mutagenesis in the extreme thermophilic eubacteria Thermus thermophilus HB8. Mol Microbiol (1992) 1.81
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology (2004) 1.77
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology (1999) 1.76
Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis (1990) 1.73
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology (2000) 1.72
Accelerating the domestication of trees using genomic selection: accuracy of prediction models across ages and environments. New Phytol (2011) 1.65
Reproductive limits of a late-flowering high-mountain Mediterranean plant along an elevational climate gradient. New Phytol (2007) 1.59
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis (1998) 1.59
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob Agents Chemother (1996) 1.58
Thalidomide in patients with acquired immunodeficiency syndrome. Arch Intern Med (1992) 1.56
Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect (2013) 1.55
Internal leaf anatomy and photosynthetic resource-use efficiency: interspecific and intraspecific comparisons. Tree Physiol (2001) 1.53
A conserved motif in S-layer proteins is involved in peptidoglycan binding in Thermus thermophilus. J Bacteriol (1996) 1.50
"Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect (2001) 1.49
Trisomy 8: an additional case with unique manifestations [correction]. Am J Med Genet (1992) 1.47
Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg (1997) 1.46
A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect (2001) 1.45
A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect (2001) 1.40
A high-transformation-efficiency cloning vector for Thermus thermophilus. Plasmid (1999) 1.40
Motor pattern of the sphincter of Oddi in patients with bilioenteric shunt: a manometric study. Am J Gastroenterol (1988) 1.39
Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns. Proc Natl Acad Sci U S A (1990) 1.39
Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies. Rev Esp Enferm Dig (1999) 1.39
Effect of selective and nonselective muscarinic blockade on cholecystokinin-induced gallbladder emptying in man. Dig Dis Sci (1992) 1.38
[Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. Rev Esp Enferm Dig (1995) 1.38
Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig (2000) 1.37
A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med (1990) 1.36
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Secretion and assembly of regular surface structures in Gram-negative bacteria. FEMS Microbiol Rev (2000) 1.35
Development of Thermus-Escherichia shuttle vectors and their use for expression of the Clostridium thermocellum celA gene in Thermus thermophilus. J Bacteriol (1992) 1.34
Sequence of the S-layer gene of Thermus thermophilus HB8 and functionality of its promoter in Escherichia coli. J Bacteriol (1992) 1.31
A thermophilic nitrate reductase is responsible for the strain specific anaerobic growth of Thermus thermophilus HB8. Biochim Biophys Acta (1998) 1.29
Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore) (2001) 1.28
Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology (1992) 1.28
Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) (1997) 1.28
Anaerobic growth, a property horizontally transferred by an Hfr-like mechanism among extreme thermophiles. J Bacteriol (1998) 1.27
Monitoring mortality as an indicator of influenza in Catalonia, Spain. J Epidemiol Community Health (1996) 1.27
Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother (1990) 1.25
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect (2013) 1.23
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (2010) 1.23
Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22
Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.22
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl (2001) 1.22
Brucellar meningitis. Rev Infect Dis (1988) 1.22
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis. Antimicrob Agents Chemother (1994) 1.20
Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam. Antimicrob Agents Chemother (1982) 1.20
Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation (2006) 1.19
Binding of 125I-labeled beta-lactam antibiotics to the penicillin binding proteins of Escherichia coli. J Antibiot (Tokyo) (1984) 1.18
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect (2007) 1.17
Cytogenetic effects in human exposure to arsenic. Mutat Res (1997) 1.16
Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplant (1997) 1.16
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
Cloning and expression in Escherichia coli of the structural gene coding for the monomeric protein of the S layer of Thermus thermophilus HB8. J Bacteriol (1991) 1.16
Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation (1998) 1.14
Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig (1998) 1.14
Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol (2005) 1.11
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11
Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect (2002) 1.11
S-layer protein from Thermus thermophilus HB8 assembles into porin-like structures. Mol Microbiol (1993) 1.10
Cavernosography in diagnosis of metastatic tumors of the penis: 5 new cases and a review of the literature. J Urol (1987) 1.09
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09
Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS (2001) 1.07
Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J (1992) 1.06
The "target sign": is it a specific sign of CNS tuberculoma? Neuroradiology (1996) 1.06
Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections. Clin Transplant (2012) 1.06
Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem (1997) 1.06
Molecular biology of S-layers. FEMS Microbiol Rev (1997) 1.06
Surface proteins and a novel transcription factor regulate the expression of the S-layer gene in Thermus thermophilus HB8. Mol Microbiol (1997) 1.06
Genetic polymorphisms and activity of PON1 in a Mexican population. Toxicol Appl Pharmacol (2004) 1.05
Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect (2005) 1.05
Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci (1996) 1.05
Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia (2006) 1.04
Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference. Dig Dis Sci (1988) 1.04
Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol Dis (2004) 1.04
Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol (1999) 1.03
Two nitrate/nitrite transporters are encoded within the mobilizable plasmid for nitrate respiration of Thermus thermophilus HB8. J Bacteriol (2000) 1.03
Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am (2001) 1.03
Postoperative infections after major heart surgery and prevention of ventilator-associated pneumonia: a one-day European prevalence study (ESGNI-008). J Hosp Infect (2006) 1.03
Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS (1990) 1.03
Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat (2009) 1.02